2024

novoMEDLINK

Entrant Company

Toolhouse

Category

Website - User Experience

Client's Name

Novo Nordisk

Country / Region

United States

novoMEDLINK™ is a unique website ecosystem built to optimize Novo Nordisk’s portfolio strategy across Therapeutic Areas, bringing together branded and unbranded communications with HCPs into one unified destination. This streamlined experience consolidates 20+ branded and unbranded sites, services such as literature fulfillment and sample ordering, and a large library of disease state information.



By integrating a customer-centric design with robust yet flexible navigational structure, the site supports a wide range of HCP content in a way that no other Pharma website does today. Personalization is woven throughout the site, including geographically-relevant imagery, designation-specific landing pages, and a modular content approach. The site provides significant value to both client and user by providing a consistent navigation experience, while providing both flexibility for each brand story to shine and a standardized format for satisfying all regulatory requirements.



As a consolidated hub for all HCP-related content, novoMEDLINK™ is driving operational efficiency and allowing Novo Nordisk to maximize its technology investments. Content Components can be used across multiple pages within this content-rich site so teams and external agencies can quickly deploy consistently-formatted assets. These videos, PDFs, podcasts, educational materials, and samples ordering systems are all housed in a master library HCP users can additionally browse.



The 6 months after launching novoMEDLINK™ saw a 50% Increase in pages per session, 20 points improved bounce rate, and increases in registration conversions, samples requests, and resource usage. Brand sites received 35,000 incremental users due to the consolidation of branded information with therapy area and educational information into a single site. (Google Analytics)



novoMEDLINK™ has increased overall exposure to Novo Nordisk products and services by 17% compared to previous individual brand site instances, while saving an estimated 23% vs. pre-consolidation budgets for HCP websites. This consolidation allows the agency to gather and analyze relevant user data that informs further refinements of website experiences and provides increasingly customized and personalized web experiences to drive ongoing HCP engagement.

Advertising
2024
Believe the Impossible

Entrant Company

Boundless Life Sciences

Category

Advertising - Advertising / Others___

Country / Region

United States

Advertising
2024
Best Hospitals

Entrant Company

Chemistry Agency

Category

Advertising - Billboard

Country / Region

United States

Website
2024
novoMEDLINK

Entrant Company

Toolhouse

Category

Website - Website Redesign

Country / Region

United States

Video, Commercial & Film
2024
A brief introduction to CRISPR-associated transposases

Entrant Company

St Jude Children's Research Hospital

Category

Video, Commercial & Film - Animation

Country / Region

United States